OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Targeting immunogenic cell stress and death for cancer therapy
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 445-460
Open Access | Times Cited: 53

Aging and cancer
Léa Montégut, Carlos López-Otı́n, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 28

Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 25

The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 25

What is the role of microbial biotechnology and genetic engineering in medicine?
Fernando Santos‐Beneit
MicrobiologyOpen (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 8

M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 6

Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access

RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access

Effect of perioperative analgesia on immunity in lung cancer
Xiaomin Fan, Ziqi Huang, Z. J. Chen, et al.
Immunobiology (2025) Vol. 230, Iss. 2, pp. 152867-152867
Open Access

Phenotypic assessment of dendritic cell maturation by cost-effective custom ELISA assays
Peng Liu, Yuhong Pan, Misha Mao, et al.
Methods in cell biology (2025)
Closed Access

Pharmacological screening to identify potential regulators of antigen presentation by dendritic cells
Liwei Zhao, Yuhong Pan, Shuai Zhang, et al.
Methods in cell biology (2025)
Closed Access

A comprehensive pan-cancer examination of transcription factor MAFF: Oncogenic potential, prognostic relevance, and immune landscape dynamics
Fengze Cai, Shining Mao, Shu‐Fen Peng, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114105-114105
Closed Access

Circulating biomarkers for diagnosis, prognosis, and treatment response prediction in cancer
Lorenzo Galluzzi, Sheila Spada
International review of cell and molecular biology (2025), pp. xiii-xvii
Closed Access

Applications of Nanotechnology in Remodeling Tumour Microenvironment for Glioblastoma Treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 4045-4064
Closed Access | Times Cited: 5

Long-distance microbial mechanisms impacting cancer immunosurveillance
Laurence Zitvogel, Marine Fidelle, Guido Kroemer
Immunity (2024) Vol. 57, Iss. 9, pp. 2013-2029
Closed Access | Times Cited: 5

Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

Two decades of advances in clinical oncology — lessons learned and future directions
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 771-780
Closed Access | Times Cited: 3

Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1
Di Liu, Mengqiu Li, Zhiyao Zhao, et al.
Cancer Research (2024) Vol. 84, Iss. 17, pp. 2806-2819
Closed Access | Times Cited: 3

Blood–Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma
Yulin Zhang, Kaiyan Xi, Yuying Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9511-9524
Closed Access | Times Cited: 2

Exosomal PD-L1 in cancer and other fields: recent advances and perspectives
Manman Lu, Yu Yang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2

The role of a dedicated Oncology Nurse Navigator in the surgical oncology pathways: 1 year experience from a General Surgery Unit in central Italy with follow up
Ilenia Merlini, Filippo Antonini, Salomone Di Saverio
Updates in Surgery (2024) Vol. 76, Iss. 5, pp. 2011-2018
Closed Access | Times Cited: 2

N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors
Vito Amodio, Pietro Paolo Vitiello, Alberto Bardelli, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top